Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Horowitz

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Blood|June 14, 2000
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)R E Champlin, N Schmitz, M M Horowitz, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Leukemia|November 1, 1996
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remissionR P Gale, T Büchner, M J Zhang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
British Journal of Haematology|November 14, 1997
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapyM J Zhang, M Baccarani, R P Gale, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Blood|June 14, 2000
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)R E Champlin, N Schmitz, M M Horowitz, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Leukemia|November 1, 1996
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remissionR P Gale, T Büchner, M J Zhang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
British Journal of Haematology|November 14, 1997
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapyM J Zhang, M Baccarani, R P Gale, et al.
Bone Marrow Transplantation|December 18, 2007
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant ResearchM R Bishop, B R Logan, S Gandham, et al.
Pageof 15